review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Crispin R Dass | |
P2860 | cites work | Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers | Q24547040 |
A protein that shuttles between the nucleus and the cytoplasm is an important mediator of RNA export | Q27931607 | ||
The nuclear pore complex: from molecular architecture to functional dynamics | Q28138909 | ||
Synthetic DNA delivery systems | Q28142096 | ||
Nucleocytoplasmic transport | Q28275907 | ||
Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus | Q28361672 | ||
A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine | Q29616154 | ||
Endocytosis and molecular sorting | Q29616706 | ||
Shuttling of pre-mRNA binding proteins between nucleus and cytoplasm | Q29618907 | ||
Apolipoprotein A-I, cyclodextrins and liposomes as potential drugs for the reversal of atherosclerosis. A review. | Q30327074 | ||
Safety assessment of selected cyclodextrins - effect on ciliary activity using a human cell suspension culture model exhibiting in vitro ciliogenesis | Q30828426 | ||
Optimisation of polyethylenimine-based gene delivery to mouse brain. | Q30840523 | ||
Rapid crossing of the pulmonary endothelial barrier by polyethylenimine/DNA complexes | Q30855917 | ||
Polyethylenimine but not cationic lipid improves antisense activity of 3'-capped phosphodiester oligonucleotides | Q31462812 | ||
Polyethylenimine-based intravenous delivery of transgenes to mouse lung. | Q31916816 | ||
Chiral separation of antisense oligonucleotides: a feasibility study | Q32059077 | ||
Lipoplexes and tumours. A review | Q33723073 | ||
Characterization of oligonucleotide transport into living cells | Q33855658 | ||
Delivery of Oligoribonucleotides to Human Hepatoma Cells Using Cationic Lipid Particles Conjugated to Ferric Protoporphyrin IX (Heme) | Q41107243 | ||
Cytoplasmic gene expression system enhances the efficiency of cationic liposome-mediated in vivo gene transfer into mouse brain | Q41110769 | ||
Parenteral gene therapy with p53 inhibits human breast tumors in vivo through a bystander mechanism without evidence of toxicity | Q41133661 | ||
1995 Whitaker Lecture: delivery of molecules, particles, and cells to solid tumors | Q41139696 | ||
Intracellular distribution and mechanism of delivery of oligonucleotides mediated by cationic lipids | Q41170129 | ||
The effect of parenterally administered cyclodextrins on cholesterol levels in the rat. | Q41181635 | ||
Endocytosis and intracellular processing accompanying transfection mediated by cationic liposomes | Q41239562 | ||
Effects of acceptor particle size on the efflux of cellular free cholesterol | Q41324104 | ||
Synthesis, Hybridization Properties, Nuclease Stability, and Cellular Uptake of the Oligonucleotide-Amino-.beta.-cyclodextrins and Adamantane Conjugates | Q41331908 | ||
Systemic gene therapy with p53 reduces growth and metastases of a malignant human breast cancer in nude mice | Q41355839 | ||
RNA transport | Q41369752 | ||
Antisense Gene Inhibition by Oligonucleotides Containing C-5 Propyne Pyrimidines | Q41548206 | ||
Cationic liposome mediated transgene expression in the guinea pig cochlea | Q41614363 | ||
Systemic gene delivery expands the repertoire of effective antiangiogenic agents | Q41649129 | ||
Lipoplex-mediated gene delivery to the lung occurs within 60 minutes of intravenous administration | Q41682660 | ||
Cationic lipids are essential for gene delivery mediated by intravenous administration of lipoplexes | Q41686157 | ||
Non-replicating Epstein-Barr virus-based plasmids extend gene expression and can improve gene therapy in vivo | Q41741739 | ||
Direct in vivo gene introduction into rat kidney | Q41767783 | ||
Carcinogenicity study of beta-cyclodextrin in F344 rats | Q42440520 | ||
Live confocal microscopy of oligonucleotide uptake by keratinocytes in human skin grafts on nude mice | Q42473901 | ||
Ultrastructural localization of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) to the abluminal plasma membrane and vesiculovacuolar organelles of tumor microvascular endothelium | Q42477247 | ||
Safety and toxicity of catheter gene delivery to the pulmonary vasculature in a patient with metastatic melanoma | Q42488361 | ||
Pretreatment with cationic lipid-mediated transfer of the Na+K+-ATPase pump in a mouse model in vivo augments resolution of high permeability pulmonary oedema | Q43503985 | ||
Optimization of cationic lipid/DNA complexes for systemic gene transfer to tumor lesions | Q43504030 | ||
Characteristics and biodistribution of cationic liposomes and their DNA complexes | Q43507884 | ||
Localization and Induced Expression of Fusion Genes in the Rat Lung | Q43845860 | ||
Effects of cationic liposome-DNA complexes on pulmonary surfactant function in vitro and in vivo | Q44174124 | ||
The influence of polymer structure on the interactions of cationic polymers with DNA and morphology of the resulting complexes | Q44284181 | ||
Periadventitial lacZ gene transfer to pig carotid arteries using a biodegradable collagen collar or a wrap of collagen sheet with adenoviruses and plasmid-liposome complexes | Q44390694 | ||
Stabilization of cationic liposome-plasmid DNA complexes by polyamines and poly(ethylene glycol)-phospholipid conjugates for efficient in vivo gene delivery | Q45090289 | ||
Enhanced anti-tumor effects with microencapsulated c-myc antisense oligonucleotide. | Q45142433 | ||
Highly efficient suicide gene expression in hepatocellular carcinoma cells by epstein-barr virus-based plasmid vectors combined with polyamidoamine dendrimer | Q45225251 | ||
Direct intratumoral gene transfer of the herpes simplex virus thymidine kinase gene with DNA-liposome complexes: growth inhibition of tumors and lack of localization in normal tissues | Q45763624 | ||
Enhanced gene expression in mouse lung by prolonging the retention time of intravenously injected plasmid DNA. | Q45855918 | ||
Evaluation of cationic liposome suitable for gene transfer into pregnant animals | Q45858269 | ||
Efficient adventitial gene delivery to rabbit carotid artery with cationic polymer-plasmid complexes | Q45858437 | ||
Cationic lipid-mediated transfection of cells in culture requires mitotic activity | Q45859684 | ||
Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. | Q45861628 | ||
Attenuation of the acute-phase response in thermally injured rats by cholesterol-containing cationic liposomes used as a delivery system for gene therapy | Q45862903 | ||
Attenuating the growth of tumors by intratumoral administration of DNA encoding Pseudomonas exotoxin via cationic liposomes | Q45865280 | ||
Effective suicide gene therapy in vivo by EBV-based plasmid vector coupled with polyamidoamine dendrimer | Q45865352 | ||
Cationic liposome-mediated intravenous gene delivery | Q45866771 | ||
Cancer Gene Therapy Using Plasmid DNA: Safety Evaluation in Rodents and Non-Human Primates | Q45866929 | ||
Development of cationic liposome formulations for intratracheal gene therapy of early lung cancer | Q45868014 | ||
Intravesical liposome-mediated interleukin-2 gene therapy in orthotopic murine bladder cancer model | Q45868408 | ||
A microsphere-liposome (microplex) vector for targeted gene therapy of cancer. II. In vivo biodistribution study in a solid tumor model | Q45869268 | ||
Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis | Q45869591 | ||
Optimization of nonviral gene transfer of vascular smooth muscle cells in vitro and in vivo | Q45870001 | ||
Cationic lipid-based delivery system for systemic cancer gene therapy | Q45870554 | ||
Percutaneous in vivo gene transfer to the peripheral lungs using plasmid-liposome complexes | Q45871018 | ||
Multiple systemic expression of human interferon-beta in mice can be achieved upon repeated administration of optimized pcTG90-lipoplex | Q45871435 | ||
Nasal application of the cationic liposome DC-Chol:DOPE does not alter ion transport, lung function or bacterial growth | Q45871596 | ||
Gene delivery from a DNA controlled-release stent in porcine coronary arteries | Q45872208 | ||
Aerosol and intravenous transfection of human alpha 1-antitrypsin gene to lungs of rabbits | Q45873756 | ||
Use of the rabbit ear artery to serially assess foreign protein secretion after site-specific arterial gene transfer in vivo. Evidence that anatomic identification of successful gene transfer may underestimate the potential magnitude of transgene ex | Q45873862 | ||
A new cationic liposome DNA complex enhances the efficiency of arterial gene transfer in vivo | Q45879391 | ||
Gene transfer into coronary arteries of intact animals with a percutaneous balloon catheter | Q45880213 | ||
Direct in vivo gene transfer into the coronary and peripheral vasculatures of the intact dog. | Q45881399 | ||
A placebo-controlled study of liposome-mediated gene transfer to the nasal epithelium of patients with cystic fibrosis. | Q45881607 | ||
Direct gene transfer into the rat pancreas using DNA-liposomes | Q45886814 | ||
Gene transduction for disseminated intraperitoneal tumor using cationic liposomes containing non-histone chromatin proteins: cationic liposomal gene therapy of carcinomatosa | Q45887018 | ||
beta-Galactosidase staining following intracoronary infusion of cationic liposomes in the in vivo rabbit heart is produced by microinfarction rather than effective gene transfer: a cautionary tale | Q45887497 | ||
Inhibition of human squamous cell carcinoma growth in vivo by epidermal growth factor receptor antisense RNA transcribed from the U6 promoter | Q45888433 | ||
Efficiency of cationic lipid-mediated transfection of polarized and differentiated airway epithelial cells in vitro and in vivo | Q45888712 | ||
Effective treatment of early endobronchial cancer with regional administration of liposome-p53 complexes | Q45888786 | ||
In vivo gene therapy with a cationic polymer markedly enhances the antitumor activity of antiangiogenic genes | Q45888989 | ||
Isolated lung liposome-mediated gene transfer produces organ-specific transgenic expression | Q45889554 | ||
Liver-directed gene transfer: a linear polyethlenimine derivative mediates highly efficient DNA delivery to primary hepatocytes in vitro and in vivo | Q45890367 | ||
In vitro gene delivery by degraded polyamidoamine dendrimers | Q46042198 | ||
Systemic Gene Expression After Intravenous DNA Delivery into Adult Mice | Q46128630 | ||
Size-dependent release of carboxyfluorescein from cetylmannoside-modified liposomes in human plasma | Q47335345 | ||
The effect of particle size and charge on the clearance rates of liposomes and liposome encapsulated drugs | Q47350227 | ||
Effect of vesicle size and lipid composition on the in vivo tumor selectivity and toxicity of the non-cross-resistant anthracycline annamycin incorporated in liposomes | Q47353590 | ||
Size dependent liposome degradation in blood: in vivo/in vitro correlation by kinetic modeling | Q47361973 | ||
Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes | Q47379316 | ||
Role of liposome size and RES blockade in controlling biodistribution and tumor uptake of GM1-containing liposomes | Q47416201 | ||
beta-Cyclodextrin derivatives as carriers to enhance the antiviral activity of an antisense oligonucleotide directed toward a coronavirus intergenic consensus sequence | Q47807988 | ||
In vivo delivery to tumors of DNA complexed with linear polyethylenimine. | Q48148822 | ||
Direct plasmid mediated transfection of adult murine brain cells in vivo using cationic liposomes | Q48174573 | ||
Intraarterial delivery of adenovirus vectors and liposome-DNA complexes to experimental brain neoplasms | Q48281974 | ||
Gene transfer in vivo with DNA-liposome complexes: lack of autoimmunity and gonadal localization | Q48398228 | ||
In vivo gene transfer into the adult mammalian central nervous system by continuous injection of plasmid DNA-cationic liposome complex | Q48529105 | ||
Safety of parenteral hydroxypropyl beta-cyclodextrin | Q49182103 | ||
Reciprocal enhancement of gene transfer by combinatorial adenovirus transduction and plasmid DNA transfection in vitro and in vivo | Q50108839 | ||
Oral gene delivery with chitosan--DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. | Q52844746 | ||
A DNA controlled-release coating for gene transfer: transfection in skeletal and cardiac muscle. | Q53942787 | ||
Uptake and intracellular fate of polyethylenimine in vivo. | Q54028209 | ||
Reduction of sphingomyelin level without accumulation of ceramide in Chinese hamster ovary cells affects detergent-resistant membrane domains and enhances cellular cholesterol efflux to methyl-beta -cyclodextrin. | Q54041688 | ||
Polyion complex micelles with protein-modified corona for receptor-mediated delivery of oligonucleotides into cells. | Q54077635 | ||
Cellular distribution of phosphorothioate oligonucleotide following intravenous administration in mice. | Q54671456 | ||
Intracellular hyperthermia for cancer using magnetite cationic liposomes: an in vivo study. | Q54965829 | ||
A local hyperthermia treatment which enhances antibody uptake in a glioma xenograft model does not affect tumour interstitial fluid pressure. | Q55478512 | ||
Hyperthermic modulation of radiolabelled antibody uptake in a human glioma xenograft and normal tissues. | Q55481402 | ||
Starburst Dendrimers: Molecular-Level Control of Size, Shape, Surface Chemistry, Topology, and Flexibility from Atoms to Macroscopic Matter | Q56486023 | ||
Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis | Q57416213 | ||
Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo | Q59067674 | ||
Systemic gene therapy: biodistribution and long-term expression of a transgene in mice | Q33867700 | ||
High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. | Q33869552 | ||
Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo | Q33892020 | ||
Recombinant platelet-derived growth factor B gene expression in porcine arteries induce intimal hyperplasia in vivo | Q33897258 | ||
In vivo gene delivery to the lung using polyethylenimine and fractured polyamidoamine dendrimers | Q33914869 | ||
Hypothesis: naked plasmid DNA is taken up by cells in vivo by a receptor-mediated process | Q33917462 | ||
Catalytic DNAs as potential therapeutic agents and sequence-specific molecular tools to dissect biological function. | Q33925818 | ||
Tumor localizers: porphyrins and related compounds (unusual metalloporphyrins XXIII) | Q34008330 | ||
Increased gene expression after liposome-mediated arterial gene transfer associated with intimal smooth muscle cell proliferation. In vitro and in vivo findings in a rabbit model of vascular injury | Q34125318 | ||
Protection of rabbit lungs from endotoxin injury by in vivo hyperexpression of the prostaglandin G/H synthase gene | Q34141454 | ||
Delivery of lipoplexes for genotherapy of solid tumours: role of vascular endothelial cells | Q34143913 | ||
Mechanism of oligonucleotide uptake by cells: involvement of specific receptors? | Q34299285 | ||
Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans | Q34345458 | ||
Plasmid DNA entry into postmitotic nuclei of primary rat myotubes | Q34345977 | ||
Polyamidoamine cascade polymers mediate efficient transfection of cells in culture | Q34347285 | ||
Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation | Q34417057 | ||
Biologically erodable microspheres as potential oral drug delivery systems | Q34423490 | ||
Expression of naked plasmid DNA injected into the afferent and efferent vessels of rodent and dog livers | Q34445077 | ||
Expression of the human cystic fibrosis transmembrane conductance regulator gene in the mouse lung after in vivo intratracheal plasmid-mediated gene transfer | Q35072251 | ||
Electron micrographic studies of transport of oligodeoxynucleotides across eukaryotic cell membranes. | Q35158452 | ||
Histone H2A-mediated transient cytokine gene delivery induces efficient antitumor responses in murine neuroblastoma | Q35308393 | ||
Percutaneous arterial gene transfer in a rabbit model. Efficiency in normal and balloon-dilated atherosclerotic arteries | Q35821965 | ||
Liposome mediated gene transfer into the rat oesophagus | Q35841171 | ||
Electroporation enhances c-myc antisense oligodeoxynucleotide efficacy | Q35858474 | ||
Modified deoxyoligonucleotides stable to exonuclease degradation in serum | Q35913882 | ||
Exposure of human ovarian carcinoma to cisplatin transiently sensitizes the tumor cells for liposome-mediated gene transfer | Q35997145 | ||
Cell-surface perturbations of the epidermal growth factor and vascular endothelial growth factor receptors by phosphorothioate oligodeoxynucleotides | Q36192928 | ||
Movement of a karyophilic protein through the nuclear pores of oocytes | Q36212178 | ||
Translocation of RNA-coated gold particles through the nuclear pores of oocytes | Q36218652 | ||
The effects of variations in the number and sequence of targeting signals on nuclear uptake | Q36219342 | ||
Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery | Q36339428 | ||
Studies on the mechanism of selective retention of porphyrins and metalloporphyrins by cancer cells | Q36467323 | ||
Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment | Q36477445 | ||
Direct transfer of transforming growth factor beta 1 gene into arteries stimulates fibrocellular hyperplasia | Q36671684 | ||
Cationic liposomes mediated delivery of antisense oligonucleotides targeted to HPV 16 E7 mRNA in CaSki cells | Q36746252 | ||
Characteristics of oligonucleotide uptake in human keratinocyte cultures | Q36754538 | ||
A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: polyethylenimine | Q36833845 | ||
Immune response in human melanoma after transfer of an allogeneic class I major histocompatibility complex gene with DNA-liposome complexes | Q37094888 | ||
A novel cationic lipid greatly enhances plasmid DNA delivery and expression in mouse lung | Q37253992 | ||
Mechanism of oligonucleotide release from cationic liposomes | Q37255679 | ||
Normal and leukemic hematopoietic cells manifest differential sensitivity to inhibitory effects of c-myb antisense oligodeoxynucleotides: an in vitro study relevant to bone marrow purging | Q37439168 | ||
Intracellular distribution of microinjected antisense oligonucleotides | Q37458928 | ||
Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides. | Q38297078 | ||
Synthesis and binding properties of oligonucleotides carrying nuclear localization sequences | Q38318398 | ||
Dynamics of the internalization of phosphodiester oligodeoxynucleotides in HL60 cells | Q38319334 | ||
Novel cationic amphiphiles as delivery agents for antisense oligonucleotides | Q38321406 | ||
Characterisation of membrane oligonucleotide-binding proteins and oligonucleotide uptake in keratinocytes | Q38324853 | ||
Antisense c-myc oligodeoxyribonucleotide cellular uptake | Q38327157 | ||
Self-assembly of polyamine-poly(ethylene glycol) copolymers with phosphorothioate oligonucleotides. | Q38331375 | ||
Biodegradable polyalkylcyanoacrylate nanoparticles for the delivery of oligonucleotides | Q38333233 | ||
Effects of polyethyleneimine on endocytosis and lysosome stability | Q38334565 | ||
Effect of serum components on the physico-chemical properties of cationic lipid/oligonucleotide complexes and on their interactions with cells | Q38338150 | ||
Mac-1 (CD11b/CD18) is an oligodeoxynucleotide-binding protein | Q38347420 | ||
Fate of cationic liposomes and their complex with oligonucleotide in vivo | Q38356723 | ||
Biodistribution and gene expression of lipid/plasmid complexes after systemic administration | Q38549855 | ||
Encapsulation of proteins for improved delivery | Q38550196 | ||
Drug targeting into the central nervous system by stereotactic implantation of biodegradable microspheres | Q38569531 | ||
Hydroxypropylcyclodextrins in parenteral use. II: Effects on transport and disposition of lipids in rabbit and humans | Q39501639 | ||
Phosphorothioate oligodeoxyribonucleotides dissociate from cationic lipids before entering the nucleus | Q39723515 | ||
Cationic porphyrins: novel delivery vehicles for antisense oligodeoxynucleotides | Q39725869 | ||
RNA export | Q40400161 | ||
Intracellular disposition and metabolism of fluorescently-labeled unmodified and modified oligonucleotides microinjected into mammalian cells | Q40409131 | ||
Mechanisms of nuclear protein import. | Q40475438 | ||
Nuclear import of polypeptides, polynucleotides and supramolecular complexes | Q40762719 | ||
Efficient delivery of transgenes to human hair follicle progenitor cells using topical lipoplex | Q40770877 | ||
Targeted killing of carcinoembryonic antigen (CEA)-producing cholangiocarcinoma cells by polyamidoamine dendrimer-mediated transfer of an Epstein-Barr virus (EBV)-based plasmid vector carrying the CEA promoter | Q40850724 | ||
Transvascular drug delivery in solid tumors | Q40854577 | ||
An overview of progress in antisense therapeutics | Q40858877 | ||
Application of membrane-based dendrimer/DNA complexes for solid phase transfection in vitro and in vivo | Q40891208 | ||
Systemic administration of cationic phosphonolipids/DNA complexes and the relationship between formulation and lung transfection efficiency | Q40895637 | ||
TGF-alpha antisense gene therapy inhibits head and neck squamous cell carcinoma growth in vivo | Q40906936 | ||
Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles | Q40906941 | ||
Transferrin-liposome-mediated systemic p53 gene therapy in combination with radiation results in regression of human head and neck cancer xenografts | Q40910125 | ||
New class of polymers for the delivery of macromolecular therapeutics | Q40917770 | ||
DNA delivery from polymer matrices for tissue engineering | Q40945294 | ||
The size of DNA/transferrin-PEI complexes is an important factor for gene expression in cultured cells | Q40975907 | ||
Optimal lipofection reagent varies with the molecular modifications of the DNA. | Q40993136 | ||
DNA-polycation nanospheres as non-viral gene delivery vehicles | Q41008174 | ||
Controlled gene delivery by DNA-gelatin nanospheres | Q41012452 | ||
P433 | issue | 1 | |
P304 | page(s) | 3-27 | |
P577 | publication date | 2002-01-01 | |
P1433 | published in | Journal of Pharmacy and Pharmacology | Q10532762 |
P1476 | title | Vehicles for oligonucleotide delivery to tumours | |
P478 | volume | 54 |